ArticleAmerican journal of translational research2018

MiR-185 inhibits tumor growth and enhances chemo-resistance via targeting SRY-related high mobility group box transcription factor 13 in non-small-cell carcinoma.

Cheng Wei Zhou et al.PubMed ↗Full text ↗

No numbers read from the abstract.